APA

Sozio F., Polilli E., D'Annunzio M., Falconi L., Di Masi F., Tontodonati M., Cosentino L., Consorte A., Di Giammartino D. & Parruti G. (20100507). Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation. : Le infezioni in medicina.

Chicago

Sozio F, Polilli E, D'Annunzio Marco, Falconi L, Di Masi F, Tontodonati M, Cosentino L, Consorte A, Di Giammartino D and Parruti G. 20100507. Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation. : Le infezioni in medicina.

Harvard

Sozio F., Polilli E., D'Annunzio M., Falconi L., Di Masi F., Tontodonati M., Cosentino L., Consorte A., Di Giammartino D. and Parruti G. (20100507). Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation. : Le infezioni in medicina.

MLA

Sozio F, Polilli E, D'Annunzio Marco, Falconi L, Di Masi F, Tontodonati M, Cosentino L, Consorte A, Di Giammartino D and Parruti G. Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation. : Le infezioni in medicina. 20100507.